A Randomized Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Breast, Ovarian, Prostate and Pancreatic Cancer Patients

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Metastatic Breast Cancer | Metastatic Prostate Cancer | Advanced/Metastatic Ovarian Cancer | Advanced/Metastatic Pancreatic Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Other eligibility criteria:

  • Speak and understand English

  • A personal history of one or more of the following:
Metastatic Breast Cancer
Advanced Ovarian Cancer (Stage III-IV)
Advanced Pancreatic Cancer (Stage III-IV)
Metastatic Prostate Cancer
  • No previous cancer germline genetic testing

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com